Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
06/11/1998 | CA2722378A1 Human antibodies that bind tnf alpha |
06/11/1998 | CA2689842A1 Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders |
06/11/1998 | CA2277580A1 Human chemokine beta-13 |
06/11/1998 | CA2274316A1 Therapeutic composition comprising the kal protein and use of the kal protein for the treatment of retinal, renal, neuronal and neural injury |
06/11/1998 | CA2274309A1 Novel dna, novel protein, and novel antibody |
06/11/1998 | CA2274305A1 Novel trh receptor |
06/11/1998 | CA2274304A1 Novel calpaines, production and use thereof |
06/11/1998 | CA2274145A1 Adaptor protein frs2 and related products and methods |
06/11/1998 | CA2274105A1 Transgenic non-human animals capable of producing heterologous antibodies |
06/11/1998 | CA2274095A1 Compositions and methods for administering pneumococcal dna |
06/11/1998 | CA2273850A1 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
06/11/1998 | CA2273845A1 Secreted proteins and polynucleotides encoding them |
06/11/1998 | CA2273827A1 Vertebrate homologues of unc-53 protein of c. elegans |
06/11/1998 | CA2273822A1 Mutants of streptococcal toxin a and methods of use |
06/11/1998 | CA2273202A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions |
06/11/1998 | CA2273199A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
06/11/1998 | CA2273198A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor |
06/11/1998 | CA2273192A1 Inactivation of hiv co-receptors as therapy for hiv infection |
06/11/1998 | CA2273184A1 Alarm related peptides and nucleic acids and diagnosis using them |
06/11/1998 | CA2273164A1 Mutant ob receptors and nucleotides encoding them |
06/11/1998 | CA2272851A1 Syndecan enhancer element and its use for targeting gene expression |
06/11/1998 | CA2224131A1 Novel human 11 cb splice variant |
06/10/1998 | EP0846950A2 Peptides useful as internal standards for microsequencing and method for their use |
06/10/1998 | EP0846771A1 Zea mays plants and transgenic zea mays plants regenerated from protoplasts or protoplast-derived cells |
06/10/1998 | EP0846770A1 Method for the expression of foreign genes and vectors therefor |
06/10/1998 | EP0846767A2 FtsL - A membrane bound protein from Streptococcus pneumoniae |
06/10/1998 | EP0846766A2 IgA Fc binding protein from Streptococcus pneumoniae |
06/10/1998 | EP0846765A1 Cell proliferation inhibitor |
06/10/1998 | EP0846764A2 Glial cell line-derived neurotrophic factor alpha receptor family |
06/10/1998 | EP0846763A2 A protein phosphatase 1 binding protein, R5 |
06/10/1998 | EP0846762A2 Novel V31 seven transmembrane receptors |
06/10/1998 | EP0846761A1 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof |
06/10/1998 | EP0846760A1 Production and use of anthelmintic agents and protective immunogens |
06/10/1998 | EP0846702A2 Soluble recombinant Alpha 5 Beta 3 adhesion receptor |
06/10/1998 | EP0846701A1 Recombinant conglutinin and process for producing the same |
06/10/1998 | EP0846700A1 Pollen Allergens |
06/10/1998 | EP0846265A1 Methods for g protein coupled receptor activity screening |
06/10/1998 | EP0846263A2 A method and kit for evaluating the metastatic tendency of tumors |
06/10/1998 | EP0846183A2 High efficiency retroviral packaging system |
06/10/1998 | EP0846181A1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS |
06/10/1998 | EP0846178A1 Allergen-xcd32 fusion proteins |
06/10/1998 | EP0846177A1 Use of a prolactin receptor or growth hormone receptor intracytoplasmic domain for achieving protein secretion |
06/10/1998 | EP0846176A1 Hybrid protein comprising t-helper cell stimulating epitopes and b-cell epitopes from the major outer membrane protein of chlamydia trachomatis and its use as a vaccine |
06/10/1998 | EP0846174A1 Methods for enhancing the production of interferon in cell culture |
06/10/1998 | EP0846173A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
06/10/1998 | EP0846172A2 Assay for identifying genes causing chromosome non-disjunction |
06/10/1998 | EP0846171A2 Chromosome 1 gene and gene products related to alzheimer's disease |
06/10/1998 | EP0846169A1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-ALPHA RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-ALPHA AND ITS ANALOGUES |
06/10/1998 | EP0846165A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof |
06/10/1998 | EP0846164A2 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease |
06/10/1998 | EP0846160A1 Methods for enhancing the production of viral vaccines in cell culture by interferon suppression |
06/10/1998 | EP0846128A2 Antimicrobial cationic peptides and methods of screening for the same |
06/10/1998 | EP0846127A1 Acylated oligopeptide derivatives having cell signal inhibiting activity |
06/10/1998 | EP0845995A1 Pharmaceutical compositions for competitively inhibiting the binding of a retrovirus to the ifn-receptor and means for diagnosis of an hiv infection |
06/10/1998 | EP0845981A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
06/10/1998 | EP0845943A1 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits |
06/10/1998 | EP0836652A4 Methods, kits, and compositions for diagnosing papillomavirus infection |
06/10/1998 | EP0812200A4 Protein purification |
06/10/1998 | EP0767797A4 Plant peptide transport gene |
06/10/1998 | EP0759069A4 Beta taipoxin as a cell growth factor and method |
06/10/1998 | EP0733106A4 Plant arabinogalactan protein (agp) genes |
06/10/1998 | EP0721346B1 Methods for inducing antigen-specific t cell tolerance |
06/10/1998 | EP0714403B1 Aqueous multiple-phase isolation of polypeptide |
06/10/1998 | EP0629210B1 Peptide linkage unit comprising methylene phosphinic acid |
06/10/1998 | EP0487627B1 Wound healing preparations containing heparanase |
06/10/1998 | EP0309569B1 Production of purified, biologically active, bacterially produced recombinant human csf-1 |
06/10/1998 | DE19652374A1 Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung Use of endothelin-conjugates in therapy, new endothelin conjugates, compositions comprising them, and to processes for their preparation |
06/10/1998 | DE19650142A1 nCL-3, a truncated calpain |
06/10/1998 | CN1184531A Method for diagnosing a patient for chlamydia |
06/10/1998 | CN1184506A DNA molecule relating to suppression of gene expression and novel protein |
06/10/1998 | CN1184505A Vaccines for plague |
06/10/1998 | CN1184504A Recombinant baculovirus insecticides |
06/10/1998 | CN1184472A Reversible protease inhibitors |
06/10/1998 | CN1184114A Alpha derivative of human tumor necrosin and its preparation |
06/09/1998 | USRE35823 Proteins useful in the regulation of κB-containing genes |
06/09/1998 | US5764656 Method for a fast scan GRA cell circuit |
06/09/1998 | US5763748 Genetic engineered dna transforming plant cell to excrete human serum albumin |
06/09/1998 | US5763740 Method of detecting prions in a sample and transgenic animal used for same |
06/09/1998 | US5763733 Antigen-binding fusion proteins |
06/09/1998 | US5763595 Nucleic acid ligands which bind covalently with protein |
06/09/1998 | US5763593 Nucleic acids encoding TBP-associated global negative regulator |
06/09/1998 | US5763591 Use for screening insulin-dependent diabetes mellitus disease |
06/09/1998 | US5763589 Human membrane protein |
06/09/1998 | US5763585 Modulators of t-cells for immunological disorders |
06/09/1998 | US5763584 Receptor activation with hepatocyte growth factor agonists |
06/09/1998 | US5763583 Process for producing solubilized protein |
06/09/1998 | US5763580 A polypeptide analogs of hgpiib c-terminal fragment, useful for diagnosis of blood clotting and thrombi |
06/09/1998 | US5763578 All-trans retinaldehyde binding protein, and antibodies thereto |
06/09/1998 | US5763575 Agonist and antagonist peptides of the C140 receptor |
06/09/1998 | US5763574 HIV-specific synthetic antigens and their use |
06/09/1998 | US5763573 GTPase activating protein fragments |
06/09/1998 | US5763572 HTLV-II peptide antigens |
06/09/1998 | US5763571 Amino acid sequences which inhibit binding |
06/09/1998 | US5763569 Polypeptides as calcium receptors to generate antibodies |
06/09/1998 | US5763568 Polypeptides |
06/09/1998 | US5763567 Human amino acid sequences which can bind to and/or neutralize heparin |
06/09/1998 | US5763566 Systematic evolution of ligands by exponential enrichment: tissue SELEX |
06/09/1998 | US5763472 Detection of microbes in water with kits having proteins |
06/09/1998 | US5763441 Administering to the patient suffering from diabetes, glioma, hemangioma, kaposi's sarcoma, ovarian/breast/pancreatic/colon and prostate cancer a benzo(g)quinoxaline compounds |
06/09/1998 | US5763416 Stimulating bone repair and regeneration |